News on research and diagnostic development for pathogenic diseases.
The system uses the Cas13 nuclease to identify target sites in various RNA viruses and then destroy them.
The firm said that its newly CE-marked test for intestinal infections is suitable for use in laboratories and hospitals, and provides results in 90 minutes.
The FDA-cleared panel includes tests for salmonella, Shiga toxin-producing Escherichia coli, Shigella, Campylobacter, and Cryptosporidium.
During the Black Death, Yersinia pestis isolates had low genetic diversity, but they diversified in multiple clades as the pandemic raged on.
The FDA clearance follows earlier US marketing approval for the firm's C. Difficile assay.
